Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
You can purchase shares of Sonnet BioTherapeutics (NASDAQ:SONN) through any online brokerage.
Other companies in Sonnet BioTherapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Entero Therapeutics (NASDAQ:ENTO) and Qualigen Therapeutics (NASDAQ:QLGN).
Sonnet BioTherapeutics has a consensus price target of $9.12.
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.95 last updated November 21, 2024 at 9:29 AM EST.
There are no upcoming dividends for Sonnet BioTherapeutics.
Sonnet BioTherapeutics’s Q1 earnings are confirmed for Wednesday, February 12, 2025.
There is no upcoming split for Sonnet BioTherapeutics.
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.